Lacticaseibacillus paracasei FJG2337 mitigate acute liver injury-related inflammatory responses, gut microbiota and liver metabolism in mice
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1674551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Siyu He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver, Probiotics, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute liver injury (ALI) has a high global prevalence but limited and suboptimal treatment options. Probiotics can help improve liver function by regulating gut microbiota, suppressing inflammatory responses, and inhibiting oxidative stress. However, substantial variations exist in the hepatoprotective efficacy of different bacterial strains. Lacticaseibacillus paracasei FJG2337 was isolated from the feces of long-lived elderly individuals, but its potential hepatoprotective effects remain unclear. In the present study, the influence of L. paracasei FJG2337 on the liver function in lipopolysaccharide (LPS)-treated mice was investigated. Our data demonstrated that L. paracasei FJG2337 ameliorated the serum parameters (including ALT, AST, and ALP) and elevated cecal short-chain fatty acids contents in mice with ALI. L. paracasei FJG2337 pre-treatment suppressed inflammatory responses and oxidative stress in ALI mice through modulating the TLR4/NF-кB and Nrf2/HO-1 pathway, respectively. Furthermore, L. paracasei FJG2337 significantly elevated the abundance of beneficial bacteria in mice and significantly reduced the harmful bacteria populations. Metabolomics analysis displayed that L. paracasei FJG2337 ameliorated liver metabolism in ALI mice, primarily affecting tryptophan metabolism, arachidonic acid metabolism, retinol metabolism, and glutathione metabolism, and so on. These results highlight that L. paracasei FJG2337 could serve as a promising probiotic intervention for patients with liver function injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Institute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, China.
- Fujian Abdominal Surgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Zitieren
APA
He, S., Yang, Y., Guo, W., Ou, R., Lv, X., & Chen, Y. (2025). Lacticaseibacillus paracasei FJG2337 mitigate acute liver injury-related inflammatory responses, gut microbiota and liver metabolism in mice. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1674551
Vancouver
He S, Yang Y, Guo W, Ou R, Lv X, Chen Y. Lacticaseibacillus paracasei FJG2337 mitigate acute liver injury-related inflammatory responses, gut microbiota and liver metabolism in mice. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1674551
BibTeX
@article{He2025,
author = {He, Siyu and Yang, Yuheng and Guo, Weiling and Ou, Rongwen and Lv, Xucong and Chen, Youting},
title = {Lacticaseibacillus paracasei FJG2337 mitigate acute liver injury-related inflammatory responses, gut microbiota and liver metabolism in mice},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1674551}
}
EUVIMED